Furthermore, exosome RNPs showed solid therapeutic potential in acute liver injury, chronic liver fibrosis, and hepatocellular carcinoma mouse models by targeting PUMA, CcnE1, and KAT5, respectively. This evidence concerns the gene KAT5 and hepatocellular carcinoma.